BMRN vs POOL · P/E 40, rev $2.85B vs P/E 18, rev $5.31B
Biomarin Pharmaceutical Inc (BMRN) versus Pool Corporation (POOL) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Pool Corporation (POOL) is a industrial distribution company listed on NASDAQ.
Latest reported BMRN revenue for 2024-12-31 was $2.85B. Net income was $426.9M. Revenue was up 18.0% from 2023-12-31 to 2024-12-31. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported POOL revenue for 2024-12-31 was $5.31B. Net income was $434.3M. Revenue was up 429.5% from 2023-12-31 to 2024-12-31. POOL currently screens at market cap $7.08B and trailing P/E 17.9.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. POOL currently screens at market cap $7.08B and trailing P/E 17.9.
Not investment advice. Open the BMRN and POOL stock pages for the full models.
Not investment advice.